Amneal Pharmaceuticals, Inc. Class A Common Stock Financial Flexibility Index
Amneal Pharmaceuticals, Inc. Class A Common Stock financial flexibility index. Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of $133.50 Million (operating CF $118.45 Million minus capex $15.05 Million) represents 0% of total liabilities ($2.78 Billion). See Amneal Pharmaceuticals, Inc. Class A Com (AMRX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2024)
Financial flexibility index of Amneal Pharmaceuticals, Inc. Class A Common Stock from 2015 to 2024. Historical Financial Flexibility Index trend for Amneal Pharmaceuticals, Inc. Class A Common Stock across 10 annual periods. Check AMRX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Amneal Pharmaceuticals, Inc. Class A Common Stock Financial Flexibility Index by Year (2015–2024)
Amneal Pharmaceuticals, Inc. Class A Common Stock financial flexibility index by year from 2015 to 2024. Year-by-year free cash flow to debt coverage for Amneal Pharmaceuticals, Inc. Class A Common Stock. For the full cash flow conversion analysis, see Amneal Pharmaceuticals, Inc. Class A Com (AMRX) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | $347.02 Million | $295.10 Million | $3.55 Billion | ▼ -18.5% |
| 2023 | 0.12x | $414.77 Million | $345.58 Million | $3.45 Billion | ▲ +177.0% |
| 2022 | 0.04x | $155.69 Million | $65.10 Million | $3.59 Billion | ▼ -47.4% |
| 2021 | 0.08x | $294.46 Million | $241.82 Million | $3.57 Billion | ▼ -32.2% |
| 2020 | 0.12x | $445.19 Million | $379.00 Million | $3.66 Billion | ▲ +307.1% |
| 2019 | 0.03x | $99.14 Million | $1.71 Million | $3.32 Billion | ▼ -70.3% |
| 2018 | 0.10x | $347.32 Million | $250.23 Million | $3.46 Billion | ▼ -50.5% |
| 2017 | 0.20x | $348.46 Million | $234.19 Million | $1.72 Billion | ▲ +18.1% |
| 2016 | 0.17x | $239.67 Million | $115.06 Million | $1.39 Billion | ▼ -7.2% |
| 2015 | 0.19x | $222.26 Million | $104.88 Million | $1.20 Billion | — |